ACHE and Alzheimer disease: Consequently, the importance of pathological changes in the cholinergic system of AD patients is reinforced by the fact that the principal strategy in the treatment of AD patients is the increase of availability of ACh by AChE inhibitors (donepezil, rivastigmine, and galantamine) [42].